Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice (Q41880812)

13 October 2017

Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice (English)

1 reference

13 October 2017

1 reference

Yulia Vugmeyster

1

1 reference

13 October 2017

David DeFranco

series ordinal

2

1 reference

13 October 2017

Debra D Pittman

series ordinal

3

1 reference

13 October 2017

Xin Xu

series ordinal

4

1 reference

13 October 2017

1 September 2010

1 reference

13 October 2017

Monoclonal Antibodies

1 reference

13 October 2017

2

1 reference

13 October 2017

571-575

1 reference

13 October 2017

5

1 reference

Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Receptor for advanced glycation end-products is a marker of type I lung alveolar cells.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958578

Biodistribution of [125I]-labeled therapeutic proteins: application in protein drug development beyond oncology

18 August 2018

1 reference

12 December 2020

sRAGE is elevated in septic patients and associated with patients outcome

1 reference

12 December 2020

Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease

1 reference

12 December 2020

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

12 December 2020

Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues

1 reference

12 December 2020

Kinetic analysis of the downregulation of epidermal growth factor receptors in rats in vivo

1 reference

12 December 2020

The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G

1 reference

12 December 2020

Use of hu-IgG-SCID mice to evaluate the in vivo stability of human monoclonal IgG antibodies

1 reference

12 December 2020

Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene

1 reference

12 December 2020

Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn

1 reference

12 December 2020

Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs

1 reference

12 December 2020

Identifiers

DOI

10.4161/MABS.2.5.13089

1 reference

13 October 2017

1 reference

13 October 2017

1 reference